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Aflatoxin contamination of staple crops, commonly
occurring in warm areas, negatively impacts human
and animal health, and hampers trade and economic
development. The fungus Aspergillus flavus is the
major aflatoxin producer. However, not all A. flavus
genotypes produce aflatoxins. Effective aflatoxin
control is achieved using biocontrol products con-
taining spores of atoxigenic A. flavus. In Africa, vari-
ous biocontrol products under the tradename
Aflasafe are available. Private and public sector
licensees manufacture Aflasafe using spores freshly
produced in laboratories adjacent to their factories.
BAMTAARE, the licensee in Senegal, had difficulties
to obtain laboratory equipment during its first year
of production. To overcome this, a process was
developed in Ibadan, Nigeria, for producing high-
quality dry spores. Viability and stability of the dry
spores were tested and conformed to set standards.
In 2019, BAMTAARE manufactured Aflasafe SN01
using dry spores produced in Ibadan and sent via
courier and 19 000 ha of groundnut and maize in
Senegal and The Gambia were treated. Biocontrol
manufactured with dry spores was as effective as
biocontrol manufactured with freshly produced
spores. Treated crops contained safe and signifi-
cantly (P < 0.05) less aflatoxin than untreated crops.
The dry spore innovation will make biocontrol manu-
facturing cost-efficient in several African countries.
Introduction
In tropical and sub-tropical climates, fungi belonging to
Aspergillus section Flavi frequently contaminate several
crops with aflatoxins (Klich, 2007; Probst et al., 2014).
Aflatoxins are highly toxic and carcinogenic compounds
that negatively impact human and animal health, and
hamper trade, income, and development outcomes in
affected nations (Wu, 2015; Udomkun et al., 2017;
JECFA, 2018). Throughout the world, the most common
causal agent of aflatoxin contamination is A. flavus
(Klich, 2007). However, there are A. flavus genotypes
that naturally lack the ability to produce aflatoxins (from
here on referred to as atoxigenic) due to defects in the
aflatoxin biosynthesis gene cluster (Ehrlich and Cotty,
2004; Chang et al., 2005; Mehl et al., 2012). Some atoxi-
genic genotypes possess superior abilities to outcom-
pete aflatoxin producers and are used as biocontrol
agents to reduce crop aflatoxin content (Dorner, 2004;
Cotty et al., 2007; Bandyopadhyay et al., 2016). Afla-
toxin biocontrol products containing atoxigenic A. flavus
genotypes as active ingredient fungi were first registered
with the United States Environmental Protection Agency
(USEPA) for use in cotton, groundnut, maize, pistachio,
almond, and fig grown in the United States (Dorner,
2004; Cotty et al., 2007; Doster et al., 2014; Ortega-Bel-
tran et al., 2019).
Aflatoxin biocontrol products commercially used in the
United States contain as active ingredient a single atoxi-
genic isolate belonging to a vegetative compatibility
group (VCG) composed solely of atoxigenic members
(Dorner, 2004; Mehl et al., 2012; Ortega-Beltran and
Bandyopadhyay, 2019). The International Institute of
Tropical Agriculture (IITA), United States Department of
Agriculture – Agricultural Research Service (USDA-
ARS), and several partners adapted and improved the
biocontrol technology for use by smallholder farmers
across sub-Saharan Africa (SSA). Technology adapta-
tion and improvement include (i) use of multiple atoxi-
genic isolates as active ingredient in a single product,
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and (ii) a manufacturing process adaptable to any coun-
try in SSA regardless of the context (Bandyopadhyay
et al., 2016). Several biocontrol products under the
tradename Aflasafe have been developed and registered
for use in various countries in SSA. Each Aflasafe pro-
duct contains, as active ingredient, a mixture of four iso-
lates belonging to diverse atoxigenic African Aspergillus
flavus VCGs (AAVs) native to the target country (Moral
et al., 2020). The normal procedure to manufacture the
biocontrol product is to multiply each active ingredient
isolate in glass bottles containing sterilized sorghum
grains, harvesting the spores in water to prepare a sus-
pension, combining the spore suspension of each active
ingredient in equal proportions, adding a polymer and a
dye, and coating sterilized sorghum grains with the
spore–polymer–dye suspension (Senghor et al., 2020).
A demonstration-scale manufacturing plant was con-
structed at IITA-Ibadan (Bandyopadhyay et al., 2016;
Schreurs et al., 2019). The plant relies on receiving a
freshly produced spore suspension of the active ingredi-
ents from a laboratory adjacent to the plant. IITA and
partners constructed another manufacturing plant in
Katumani, Kenya, to produce Aflasafe KE01, developed
for use in Kenya, which also has its own spore produc-
tion laboratory. Subsequently, a third plant was con-
structed in Kahone, Senegal, by BAMTAARE, a private
company licensed to manufacture and distribute Afla-
safe SN01, the product used in Senegal and The Gam-
bia (Senghor et al., 2021). Aflasafe SN01 is registered
with Le Comite Sahelien des Pesticides of Comite Inter-
Etate pour la Lutte contre la Secheresse au Sahel
(CSP/CILSS), the regulatory agency responsible for reg-
istering pesticides in 13 countries of the Sahel region.
However, during its first year of planned operation,
2019, BAMTAARE had challenges to set up the spore
production laboratory. BAMTAARE had a large order
from a major groundnut processor that planned to work
with a farmer cooperative to produce aflatoxin-safe
groundnut and there was the risk of failing to deliver the
order.
With an unfinished spore production laboratory, manu-
facturing the product was not possible. To make avail-
able large amounts of spores, around 800 fragile bottles
with spores from Ibadan, Nigeria, could have been sent
via air courier to Senegal, but that practice is expensive,
perilous, and could have resulted in poor-quality active
ingredients. Thus, to produce Aflasafe SN01 for use in
the 2019 cropping season in Senegal and The Gambia,
a process to dry the spores to a small volume was
developed. The dry spores were sent via courier to
Kahone, Senegal, where BAMTAARE staff combined
them with the other ingredients at required rates and
successfully manufactured the product to treat circa
19 000 ha of groundnut in Senegal and The Gambia.
We tested the hypothesis of whether biocontrol prod-
ucts manufactured using the conventional process and
the new one differed in effectiveness to limit aflatoxin
content in groundnut and maize grown in The Gambia
and Senegal. The results of our investigations indicate
that biocontrol was highly effective in limiting aflatoxin
contamination regardless of whether dry spores or
freshly produced spores were used to manufacture the
product. Use of dry spores to manufacture biocontrol
products in Senegal and elsewhere is poised to simplify
the manufacturing process, ensure high-quality products,
reduce production costs, and consequently make the
products cheaper to farmers.
Results
Viability and purity of dry spores
There were no differences in viability of the dry spores
and the freshly harvested spores, regardless of isolate
and storage period (data not shown). In addition, the dry-
ing process and storage period did not result in detect-
able contamination of the spores by other microbes.
Spore production in products manufactured using dry
spores and freshly harvested spores
After incubation, in all of the paired comparisons, biocon-
trol products manufactured with dry spores produced
similar number of spores (P > 0.05) as products manu-
factured with freshly harvested spores. This occurred
regardless of isolate evaluated and period for which the
dry spores were stored (Table 1). In addition, storage
period had no effect on the number of spores produced.
For example, spore yield in products manufactured with
M21-11 dry spores stored for 2 and 30 days were
13.58 9 105 spore grain1 and 13.39 9 105 spore
grain1, respectively (Table 1). Although not statistically
significant, there were some cases in which lower or
higher sporulation was detected in either dry spore- or
fresh spore-based products, but there were no consis-
tent trends for specific isolates, storage period, or
whether the spores were freshly harvested or dried.
A more detailed analysis revealed some differences
for a few of the evaluations. For example, there was sig-
nificantly (P < 0.05) higher mean spore production of the
combined four isolates in products manufactured with
fresh spores in Day 2 than in those produced with dry
spores stored for 5, 10, and 30 days but also in those
conventionally produced with fresh spores in Day 10 and
15 (Table 2). The rest of the treatments formed an inter-
mediate group between the lower and higher spore-pro-
ducing treatments. When combining values of the four
isolates in products made with freshly produced and dry
spores, higher (P < 0.05) spore production occurred on
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Day 2 compared other days. Similarly, a separate analy-
sis for dry spore product revealed significantly higher
(P < 0.05) spore production on Day 2. On the other
hand, pooling all data together – regardless of isolate
and days of storage – showed no differences (P > 0.05)
in number of spores produced in products made with
freshly produced and dry spores. Also, across days and
treatments, all isolates had similar spore production val-
ues (P > 0.05).
Quality test of biocontrol products manufactured
manually and industrially using dry spores
All experimental products manufactured in Ibadan with
dry spores yielded grains colonized exclusively by the
atoxigenic A. flavus isolate that was inoculated. None of
the grains of any of the experimental products contained
any other microorganism.
Similarly, each batch of biocontrol product manufac-
tured in Kahone with dry spores had carrier grains colo-
nized exclusively by A. flavus and only fungi belonging
to one of the four atoxigenic AAVs of Aflasafe SN01
were detected. None of the grains contained any other
microorganism. Each atoxigenic AAV composed
25  3% of the fungi coated on the carrier grains. The
number of spores on each g of biocontrol product was,
on average, 3500  300.
Aflatoxin levels in treated and untreated maize and
groundnut grains
2019 – Dry spore product vs. Conventional product in
The Gambia. Total aflatoxin content in treated
groundnut was never above 2 parts per billion (ppb),
regardless of formulation used and region where the
trials were conducted (Table 2). Both dry spore and
conventional formulations were equally effective in
limiting aflatoxin contamination (P < 0.05). In contrast,
total aflatoxin content in untreated groundnut ranged
from 18 to 190 ppb. The variance in treated crops was
negligible (up to 0.1) while in untreated crops it ranged
from 238 to 2247 (Table 2). The Kruskal–Wallis test
revealed that all treated crops, regardless of formulation
and region, had statistically similar aflatoxin levels but
significantly less than those of untreated crops
(P < 0.0001). Aflatoxin reductions in treated crops
ranged from 95.5% to 97.1% (Table 2).
2018 (conventional product) and 2019 (dry spore
product). In The Gambia, commercial use of conven-
tional product by farmers belonging to the National Food
Security, Processing and Marketing Corporation
(NFSPMC) in 2018 resulted in total aflatoxin levels
ranging from 1 to 4 ppb while untreated groundnut had
from 2 to 170 ppb (Senghor et al., 2021; Table 3).
Table 1. Spores produced per carrier grain of biocontrol product manually manufactured with spores of atoxigenic Aspergillus flavus isolates
subjected to the vacuuming and drying process compared to product conventionally manufactured with freshly produced spores.
A. flavus isolatea
CFU/grain 9 106 b,c
Day 2 Day 5 Day 10 Day 15 Day 30
Dry Fresh Dry Fresh Dry Fresh Dry Fresh Dry Fresh
M2-7 132.9 140.8 119.8 131.2 119.0 116.6 121.2 138.8 111.2 136.1
M21-11 135.8 130.9 113.3 128.8 116.4 131.5 135.8 105.9 133.9 115.1
MS14-19 133.0 136.7 113.5 126.0 111.3 111.4 123.0 101.7 112.6 119.8
SS19-14 124.9 136.1 116.1 115.1 117.4 119.8 120.0 122.2 112.9 122.1
Mean per treatmentd 130.8AB, z 136.1A 115.7B, y 125.3AB 116.0B, y 119.8B 125.0AB, yz 117.1B 117.7B, yz 123.3AB
Mean per daye 133.5Z 120.5Y 117.9Y 121.0Y 120.5Y
Overall meanf 122.7
a. The four atoxigenic isolates of A. flavus are the active ingredient fungi of the aflatoxin biocontrol product Aflasafe SN01, registered for use in
Senegal and The Gambia.
b. CFU: Colony Forming-Units. CFU values were calculated using a turbidimeter (Agbetiameh et al., 2019).
c. In Day 2 values, Dry refers to CFU/grain of a product manually manufactured with 7-d-old spores filtered, dried for 48 h at 37°C, and stored
for 2 days prior to manufacture (e.g. for M2-7: 132.9 9 106). Fresh (e.g. for M2-7: 140.8 9 106) refers to CFU/grain of a product made with
spores harvested within 20 min prior to manufacture. The same rationale applies to other comparisons: products made with spores dried and
stored for 5, 10, 15, or 30 days, and compared with products made conventionally with freshly harvested spores. Both types of products were
incubated in a moist environment for 7 days at 31°C. Then, grains were shaken in water, and CFU per carrier grain calculated. None of the val-
ues in any of the individual atoxigenic isolate comparisons (i.e. Dry vs Fresh at each day) were significantly different from each other by Stu-
dent’s t-test (a = 0.05).
d. Mean CFU values of the four isolates in each day, in each treatment. Values with the same uppercase letters are not significantly different
(Tukey’s HSD, a = 0.05). Values for Dry spore treatments were compared separately and those with the same lowercase letter are not signifi-
cantly different (Tukey’s HSD, a = 0.05).
e. CFU values of the four isolates in both Dry and Fresh treatments, at the indicated date. Values with the same uppercase letters are not sig-
nificantly different (Tukey’s HSD, a = 0.05).
f. Mean CFU/grain values of all isolates, in all treatments, at each day.
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Aflatoxin reductions in treated groundnut ranged from
82% (avg. aflatoxin level in corresponding untreated
groundnut = 12.8 ppb) to 96% (avg. aflatoxin level in
corresponding untreated groundnut = 53.1 ppb).
Commercial use of dry spore product by NFSPMC
farmers in 2019 resulted in aflatoxin levels ranging from
not detectable to 3 ppb (Table 3). On the other hand,
the corresponding untreated groundnut had aflatoxin
levels ranging from 14 to 380 ppb. Treated groundnut
had 98% to 99% less aflatoxin than untreated groundnut.
Treated groundnut by farmers participating in a Food
and Agriculture Organization (FAO) scheme during
2019, also with dry spore product, had aflatoxin levels
ranging from 1 to 4 ppb. Treated groundnut by FAO
farmers had 97.5–98.0% less aflatoxin than untreated
groundnut. Aflatoxin levels in all treated crops, regard-
less of formulation, year, region, and farmers’ organiza-
tion were statistically similar but significantly different
from untreated crops (P < 0.0001). In addition, there
were significant (P < 0.0001) differences in aflatoxin
content among untreated crops. Overall, untreated crops
from 2018 contained less aflatoxin than those from 2019
(Table 2).
In Senegal, commercial use of conventional product
by BAMTAARE farmers in 2018 on groundnut and
maize resulted in 2.2–3.7 ppb total aflatoxin while in
untreated crops aflatoxin levels ranged from 5.5 to
51.3 ppb (Table S1). Aflatoxin reductions in treated
crops ranged from 55% (avg. aflatoxin level in corre-
sponding untreated crop = 5.3 ppb) to 94% (avg. afla-
toxin level in corresponding untreated crop = 37.8 ppb).
Also in Senegal, but in 2019 and with dry spore product,
crops treated by either BAMTAARE and ASPRODEB
farmers had aflatoxin levels ranging from 2 to 3 ppb
while corresponding untreated crops had aflatoxin levels
ranging from 2.5 to 51.2 ppb (Table S1). Aflatoxin
reductions in treated crops ranged from 15% (avg. afla-
toxin level in corresponding untreated crop = 2.5 ppb) to
96% (avg. aflatoxin level in corresponding untreated
crop = 51.2 ppb).
Regardless of country, product, crop, year, or farmer
organization, variance was very stable in treated crops,
always < 2 (except for 1 case in which the variance was
30.5). In contrast, the variance went up to 3402 and
6524 in untreated crops in Senegal and The Gambia,
respectively (Table 3 and Table S1).
Discussion
The current study reports (i) the pathway to manufacture
an aflatoxin biocontrol product in Senegal using a novel
methodology for IITA and partners, and (ii) the effective-
ness of the product in commercially grown crops in both
Senegal and The Gambia. A newly constructed manu-
facturing facility in Kahone by the company BAMTAARE
had an incomplete spore production laboratory. Thus,
manufacturing the product Aflasafe SN01 for use during
the 2019 cropping season was not feasible. To over-
come this, the active ingredient spores were produced in
Ibadan, Nigeria, and harvested into a dry powder
(Fig. 1A–D). Laboratory tests showed both that the via-
bility of the dry spores was unaffected and that products
Table 2. Aflatoxin content in groundnut sampled from (i) fields treated with the biocontrol product Aflasafe SN01 formulated either convention-
ally or with dry spores, and (ii) untreated fields in two regions of The Gambia during the 2019 cropping season.
Region Formulationa Treatmentb n
Total aflatoxin (ppb)c
Variance Red (%)eMin Max Averaged
Central River Dry spores Treated 10 2.0 2.0 2.0b* 0.0 96.8
Untreated 10 18.0 170.0 62.5a 1986.7
Conventional Treated 10 2.0 2.0 2.0b** 0.0 95.5
Untreated 10 25.0 70.0 44.0a 237.8
North Bank Dry spores Treated 10 2.0 2.0 2.0b* 0.0 97.1
Untreated 10 25.0 190.0 68.0a 2247.1
Conventional Treated 10 1.0 2.0 1.9b* 0.1 95.7
Untreated 10 25.0 100.0 44.0a 476.7
a. Dry spore refers to product manufactured in Kahone, Senegal, in 2019 with a new process using dry spores produced in Ibadan, Nigeria.
Conventional refers to product manufactured in Ibadan during 2018 using the standard process previously described (Bandyopadhyay et al.,
2016). All farmers belong to the National Food Security, Processing and Marketing Corporation of The Gambia.
b. Treated refers to fields to which Aflasafe SN01, regardless of formulation, was applied at the rate of 10 kg ha-1. Untreated were nearby fields
in which no biocontrol product was applied and were separated by at least 200 m from corresponding treated field.
c. Aflatoxin values are in parts per billion (ppb).
d. Means of aflatoxin values were compared independently between treated and untreated crops in each formulation type and each region.
Treated values with one (*) or two asterisks (**) significantly differed from corresponding untreated values by Student’s t-test (a = 0.05 and
0.01, respectively). In addition, values in each treatment were compared regardless of region, treatment, and formulation. Values with the same
lowercase letter are not significantly different (Kruskal–Wallis test, a = 0.05).
e. Percentage reduction was calculated as follows: ([mean of untreated  mean of Aflasafe SN01 treated]/mean of untreated) 9 100.
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manufactured with dry spores yielded similar fungal
reproduction as those manufactured with freshly har-
vested spores (Table 1). Products manufactured either
with the conventional method or with dry spores were
equally effective at limiting aflatoxin contamination in
groundnut and maize commercially grown by smallholder
farmers in The Gambia and Senegal. Our inferences are
based on 2-year results from 770 fields (385 treated,
385 untreated; Tables 2 and 3, Fig. 3). Most treated
crops (98%) had total aflatoxin levels at or below 4 ppb
(EU tolerance threshold). In contrast, untreated crops
had up to 150 and 380 ppb total aflatoxin in Senegal
and The Gambia, respectively.
Development, testing and registration of an aflatoxin
biocontrol product containing atoxigenic isolates of A. fla-
vus as active ingredients can take over a decade. There-
after, several actions are needed to manufacture and
distribute the product at scale (Ortega-Beltran and
Bandyopadhyay, 2019; Schreurs et al., 2019; Andrews
et al., 2020; Konlambigue et al., 2020). First, a strategy
must be developed to guide the commercialization
process. Then, private sector companies evaluate the
business case to invest in the technology. Interested
companies are vetted to select the most suitable one to
which the biocontrol technology is licensed for manufac-
turing and/or distribution. However, many factors can
delay the construction, fine-tuning, and commissioning of
a manufacturing facility. Delivery of equipment to pro-
duce the spores and/or manufacture the biocontrol pro-
duct per se, and/or to verify the quality of the finished
product may be delayed for several reasons (e.g. ship-
ping time, custom issues, and unexpected damage).
The first aflatoxin biocontrol product manufacturing
plant – in Phoenix, Arizona – was set up with two labo-
ratories, one for spore production and another for quality
tests, and a manufacturing hall (Cotty et al., 2007). Simi-
larly, the first two aflatoxin biocontrol manufacturing
plants in Africa had the two laboratories and the manu-
facturing hall (Bandyopadhyay et al., 2016). On the other
hand, the biocontrol product Afla-Guard is manufac-
tured in the United States with spores produced in Japan
by a third-party service provider (Dorner, 2004).
Table 3. Aflatoxin content in groundnut sampled from (i) fields treated with the biocontrol product Aflasafe SN01 formulated either convention-
ally (2018) or with dry spores (2019), and (ii) untreated fields in the Central River, North Bank, and West Coast regions of The Gambia.
Region
Farmers
organizationa Year Formulationb Treatmentc n
Total aflatoxin ppbd
Red (%)fMin Max Averagee Variance
Central River NFSPMC 2018 Conventional Treated 15 2.0 3.0 2.1g** 0.1 96.0
Untreated 15 11.0 170.0 53.1de 1846.0
NFSPMC 2019 Dry spores Treated 15 1.0 3.0 2.0g** 0.3 98.5
Untreated 15 65.0 380.0 133.8a 6524.3
North Bank NFSPMC 2018 Conventional Treated 15 1.0 3.0 2.3g** 0.4 82.0
Untreated 15 2.0 30.0 12.8f 92.0
NFSPMC 2019 Dry spores Treated 15 ND 2.0 1.1g** 0.5 98.0
Untreated 15 14.0 120.0 53.1cde 690.1
West Coast NFSPMC 2018 Conventional Treated 15 2.0 4.0 2.3g** 0.4 93.6
Untreated 15 12.0 71.0 35.9e 292.0
NFSPMC 2019 Dry spores Treated 15 ND 3.0 1.5g** 0.8 98.8
Untreated 15 22.0 150.0 75.5bcd 1786.1
Central River FAO—Njao 2019 Dry spores Treated 10 2.0 3.0 2.3g** 0.2 98.0
Untreated 10 87.0 120.0 100.0ab 107.6
FAO—Kaur 2019 Dry spores Treated 10 1.0 4.0 2.1g* 0.5 97.8
Untreated 10 59.0 210.0 96.4abc 3167.8
FAO—Niani 2019 Dry spores Treated 10 2.0 2.0 2.0g** 0.0 97.5
Untreated 10 49.0 110.0 79.9abc 385.4
FAO—Sami 2019 Dry spores Treated 10 2.0 2.0 2.0g** 0.0 97.9
Untreated 10 77.0 120.0 93.2ab 183.3
a. NFSPMC: National Food Security, Processing and Marketing Corporation of The Gambia. FAO: Food and Agriculture Organization. Farmers
worked with FAO in four villages in Central River: Njao, Kaur, Niani and Sami.
b. Dry spore refers to product manufactured in Kahone, Senegal, in 2019 with a new process using dry spores produced in Ibadan, Nigeria.
Conventional refers to product manufactured in Ibadan during 2018 using the standard process previously described (Bandyopadhyay et al.,
2016).
c. Treated refers to fields to which Aflasafe SN01, regardless of formulation, was applied at the rate of 10 kg ha-1. Untreated were nearby fields
in which no biocontrol product was applied and were separated by at least 200 m from corresponding treated field.
d. Aflatoxin values are in parts per billion (ppb).
e. Means of aflatoxin values were compared independently between treated and untreated crops in each region, famers’ organization, and year.
Treated values with one (*) or two asterisks (**) significantly differed from corresponding untreated values by Student’s t-test (a = 0.01 and
0.001, respectively). In addition, values in each treatment were compared regardless of region, farmers organization, year, treatment, and for-
mulation. Values with the same lowercase letter are not significantly different (Tukey’s HSD, a = 0.05).
f. Percentage reduction was calculated as follows: ([mean of untreated  mean of Aflasafe SN01 treated]/mean of untreated) 9 100.
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Therefore, IITA considered feasible seeking a cost-effec-
tive method to produce dry spores to supply manufactur-
ers of aflatoxin biocontrol products in African countries
with active ingredient spores. In 2019, production of
spores at Kahone was planned for manufacture of Afla-
safe SN01 but the laboratory to produce them was not
finished on time. A method to produce dry spores was
thus rapidly developed using commonly available labora-
tory equipment (Fig. 1) so as to not lose the cropping
season. We found that drying the spores had no effect
on their viability compared to freshly harvested spores.
There were some instances in which higher or lower
spore production occurred in products made with dry
spores but there were no consistent trends to associate
lower spore production in either type of formulation
(Table 1). In general, experimental products manufac-
tured with dry spores stored for up to 30 days had simi-
lar fungal reproduction levels as products manufactured
with freshly harvested spores when incubated for 7 days
at 35°C (Table 1). Based on those results BAMTAARE
decided to manufacture the product in Kahone with
spores produced and dried in Ibadan.
In Kahone, appropriate quantities of dry spores (5 g
from each of the four atoxigenic isolates of A. flavus
composing Aflasafe SN01) were combined with required
volumes of water, polymer, and blue dye to produce 1
ton of biocontrol product (Fig. 2). After coating, the pro-
duct was packaged and stored. Quality tests of samples
collected from each of the 360 batches produced
(500 kg per batch) revealed that the product had same
quality as that produced with freshly harvested spores:
there was absence of contamination, only Aflasafe SN01
AAVs were present in the carrier grains, and appropriate
number of viable spores were coated per g of product.
Those tests were conducted in the Quality Test labora-
tory of the facility in Kahone, which was finished on time.
A total of 190 tons of Aflasafe SN01 were manufactured
using this process allowing treatment of 19 000 ha of
groundnut and/or maize. After confirming its high quality,
the product was bought by commercial farmer organiza-
tions in Senegal and The Gambia. In addition, 1 ton of
the product was sent to Mali for research field effective-
ness trials in maize, sorghum, and groundnut (unpub-
lished results). It is important to note that the 4 kg of dry
spores sent to Kahone are sufficient to produce 200 tons
of the biocontrol product (although 190 tons were pro-
duced).
Although promising results were obtained in the labo-
ratory in Ibadan and Kahone, the true value of the dry
spore product was revealed when tested in commercial
fields paired with untreated fields. Moreover, it was nec-
essary to compare the innovation’s performance with
that of biocontrol product manufactured in the conven-
tional manner (manufactured the previous year, 2018, in
Ibadan and sent via sea freight to Senegal). Field evalu-
ations revealed that both products were equally effective
in limiting aflatoxin contamination. Groundnut treated
with either product had very low total aflatoxin levels (at
or below 2 ppb) while in nearby crops the aflatoxin
levels were in many cases extremely unsafe (Table 2).
Despite being unpaired comparisons and conducted in
different years, crops treated in The Gambia with con-
ventional product in 2018 by NFSPMC farmers (Senghor
et al., 2021; Table 3) and with dry spore product in 2019
Fig. 1. A brief description of the process to dry spores of atoxigenic isolates of Aspergillus flavus. Harvesting of fungal spores from colonized
sorghum grains using sterile funnels with the stem covered with a sterile 1.7-mm2 sieve (A). Harvested fungal spores in suspension in a 250 ml
glass bottle (B). Vacuum-dried fungal spores on Tyvek membrane (lining the sieve in a B€uchner funnel) being collected using a sterile spatula
(C). Spore powder transferred to a sterile glass vial and ready for drying in the oven; note minimum humidity at the bottom of the vial (D).
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by NFSPMC and FAO farmers (Table 3) harboured very
low aflatoxin levels. In Senegal, crops treated in 2018 by
BAMTAARE farmers (conventional product) and in 2019
by BAMTAARE and ASPRODEB farmers (dry spore pro-
duct) had safe aflatoxin levels (Fig. 3; Table S1). In con-
trast, untreated crops in each of the two years, in both
countries, contained in most cases, on an average, dan-
gerous aflatoxin content.
Production of several biopesticides having as active
ingredient spores of a fungus is challenged by difficulties
to mass-produce and harvest the spores, appropriate for-
mulation procedures, and formulated product stability
(Bateman, 2004; Jaronski and Mascarin, 2013). Viability
of the spores may be reduced or lost during harvesting
and/or manufacturing. For example, the viability of dry
spores of Trichoderma harzianum, which controls sev-
eral plant pathogens, is highly dependent on the drying
and dehydration temperature as well as the conditions in
which the spores are stored (Fernandez-Sandoval et al.,
2012). Spore viability of several fungi is also dictated by
the type and concentrations of additives and protectants
applied to the spores (Harman et al., 1991; Stephan and
Zimmerman, 1998). On the other hand, mass production,
harvesting and processing of spores of atoxigenic iso-
lates of A. flavus is relatively simple to achieve (Senghor
et al., 2020). In addition, aflatoxin biocontrol products
remain stable for well over 2 years (unpublished results).
In the current study, additives or protectants were not
incorporated into the dry spores during storage and ship-
ment; the spores were kept solely as a mass of dry pow-
der. Part of the results of the current study demonstrates
that Aspergillus spores subjected to industrial processes
are not fragile as spores of many other fungi. Indeed,
several studies report that Aspergillus spores are sturdy.
For example, viability of spores of another Aspergillus
species, A. niger, is minimally affected when subjected
to severe vacuuming conditions and high temperatures
(Davis et al., 1963) and even to high levels of radiation
(Cortes~ao et al., 2020).
Prior to industrial manufacturing of aflatoxin biocontrol
products in Africa, the laboratory-scale archetype pro-
cess consisted in inoculating sterile sorghum grain with
spore suspensions of the active ingredient fungi, incubat-
ing the grain at 31°C for 18 h to allow internal fungal
growth, and drying the inoculated grain for 4 days at
55°C (Atehnkeng et al., 2014). Viability of fungi compos-
ing products manufactured in that manner was not
affected by the drying process and the products were
highly effective in limiting aflatoxin contamination
(Bandyopadhyay et al., 2016, 2019) – although their pro-
duction was not cost-effective. Therefore, it was not sur-
prising to find that both the relatively gentle vacuuming
conditions and the drying step (37°C, 2 days) did not
affect the viability of the spores as demonstrated by the
field effectiveness of the dry spore product (Tables 2
and 3; Fig. 3). Reasons for superior resilience of Asper-
gillus spores compared to those of other fungi used in
biocontrol formulations deserve further investigations.
Cole and Dorner (2001) patented a method to produce
aflatoxin biocontrol products by coating grain with dry
spores of atoxigenic fungi diluted in a vegetable oil and
then adding a siliceous material in a separate step ‘to
form a free-flowing formulation which can be directly
applied to soil’. The method used in Kahone is different.
The spores were diluted in water and then mixed with a
polymer and blue dye. This master suspension was then
coated in a single step using a seed treater. Materials to
aid in the performance of the dry product were not
(a) (b)
Fig. 2. Manufacturing facility in Kahone, Senegal where a seed treater (T) is used to coat roasted sorghum grains with a mixture of spore sus-
pension, blue food colorant and a polymer (A). Biocontrol product temporarily stored in a 1-ton bag and ready to be packaged in 5 kg plastic
bags (B).
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added. The blue dye was added to differentiate the pro-
duct from regular sorghum.
The aflatoxin biocontrol technology, developed for use
in the United States (Cotty et al., 2007), was adapted
and improved for use in SSA. In the United States, criti-
cal work was conducted to determine best formulations
and substrates for atoxigenic isolates to perform effec-
tively in the field and outcompete toxigenic fungi (Cole
and Dorner, 2001; Dorner, 2004; Cotty et al., 2007;
Jaime-Garcia and Cotty, 2008; Jaime et al., 2014).
Efforts described in the current study are part of ongoing
actions to further improve the archetype of the
technology, making it more versatile and easier for man-
ufacturers to produce the biocontrol product, and less
expensive to smallholder farmers without compromising
its effectiveness. The laboratory-scale process to dry the
spores, however, needs further improvement to make it
more cost-efficient. Some instruments allow harvesting
spores using dry processes to produce commercial
biopesticides (Bateman, 2004). A highly effective biopes-
ticide produced with spores harvested in a dry manner is
Green Muscle that has a Metarhizium anisopliae var.
acridum isolate as active ingredient for the control of
grasshoppers and locusts (Douthwaite et al., 2001;
(a)
(b)
Fig. 3. Trials conducted in six regions in Senegal with conventional formulation in 2018 (A) and dry spore formulation in 2019 (B). The percent-
age of groundnut and maize crops in each of four total aflatoxin concentration categories is indicated by different colours. The outer circle
shows Aflasafe SN01-treated crops while the inner circle shows untreated crops. For groundnut, there were 150 and 120 farmer field trials in
2018 and 2019, respectively. For maize, there were 90 and 70 farmer field trials in 2018 and 2019, respectively. In all cases, half of the trials
were treated and the rest untreated.
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Schreurs et al., 2019). Directly dislodging and concen-
trating spores from fermentation medium using an indus-
trial spore harvester would eliminate the need to harvest
spores from suspension and the drying step. This will
result in faster, cheaper production of the spores of the
active ingredient isolates.
Manufacturers procuring dry spores do not need to
construct a laboratory to produce fresh spores. Opting
for the dry spore innovation results in reduced construc-
tion, capital investment, and running costs, thus making
the biocontrol product cheaper for farmers. Moreover,
availability of dry spores, which have a shelf-life of at
least 1 year (unpublished results), will reduce the lead
time to manufacture the product once clients confirm
their order. The reduced volume of the active ingredients
is an advantage to manufacturers since the spores can
be procured and stored in a refrigerator until use. In
addition, high spore quality and reduced risk of product
contamination can result from using dry spores. Manu-
facturers in Nigeria and Tanzania have decided to use
dry spores produced by IITA (a non-profit institution) at
cost through a public–private partnership.
Contamination events in aflatoxin-prone areas are
increasing in both numbers and severities. Farmers rely
on rapid development and deployment of effective,
affordable tools to produce safe crops. The actions
reported in this work are examples of how relatively fru-
gal, but well envisioned and coordinated efforts can
overcome infrastructure limitations to make implementa-
tion of aflatoxin management a reality. A much-needed
innovation was rapidly conceptualized, developed,
tested, and validated in the laboratory, and used industri-
ally to produce a reliable field aflatoxin mitigation tool.
Thousands of commercial farmers in Senegal and The
Gambia had access to the tool and used it as a part of
an integrated aflatoxin management programme that
included pre- and post-harvest interventions. Most farm-
ers using the integrated management programme were
able to produce crops with safe aflatoxin content.
Delays in availability of an aflatoxin biocontrol product
and failure to implement proper aflatoxin management
can cause unnecessary aflatoxin exposure, which is high
in both Senegal and The Gambia (Kuniholm et al., 2008;
Watson et al., 2015). At harvest, aflatoxin levels in
untreated crops reached up to 170 ppb in 2018 and up
to 380 ppb in 2019. Those levels can increase under
sub-optimal storage (Senghor et al., 2020). Only a small
fraction of the untreated crops met the stringent EU stan-
dards and a large proportion of the untreated crops had
insufficient quality to be considered safe for human con-
sumption (Tables 2 and 3, Fig. 3). With an available
manufacturing facility in Kahone with capacity to produce
10 tons per day of Aflasafe SN01 for use in Senegal,
The Gambia, and Mali, food safety and farmers’ income
in the region are expected to significantly improve. Of
course, such improvements are highly dependent on use
of an integrated aflatoxin management system converg-
ing necessary technologies, policies, and health inter-
ventions to significantly reduce aflatoxin contamination
throughout the value chain.
Experimental procedures
Fungi constituting the aflatoxin biocontrol product
Aflasafe SN01
The biocontrol product Aflasafe SN01 contains as active
ingredient the atoxigenic A. flavus isolates SS19-14,
MS14-19, M2-7 and M21-11. These isolates belong to
AAV-SS19-14, AAV-MS14-19, AAV-M2-7, and AAV-M21-
11, respectively. The four AAVs have been detected
across Senegal (Diedhiou et al., 2011; Senghor et al.,
2020) and The Gambia (Senghor et al., 2021). The pro-
duct effectively reduces aflatoxin contamination of maize
and groundnut in both Senegal (Senghor et al., 2020)
and The Gambia (Senghor et al., 2021).
Production of Aflasafe SN01 active ingredient
To prepare the active ingredient of Aflasafe SN01, work-
ing cultures were made from mother cultures (maintained
at IITA-Ibadan in silica grains, for long-term storage) of
each of the four atoxigenic AAVs constituting the prod-
uct. Each isolate was grown on 5–2 agar [5% V8 Juice
(Campbell Soup Company, Camden, NJ, USA), 2%
Bacto-agar (Difco Laboratories Inc., Detroit, MI, USA),
pH 6.0)] for 5 days at 31°C. Spores were dislodged and
suspended in 0.1% TWEEN80 and adjusted to 106
spores ml-1 using a turbidimeter (Atehnkeng et al.,
2014).
Production of billions of spores is possible when
independently inoculating each atoxigenic isolate on
several bottles containing autoclaved sorghum grain
(Agbetiameh et al., 2019). In the current study, each
atoxigenic isolate was inoculated in six 250-ml glass
bottles containing sorghum grain previously pre-condi-
tioned to 30% moisture content. The pre-conditioning
was done in sterile 1-l plastic bottles rolled for 4 h on
a 240 Vac Benchtop Roller (Wheaton, Millville, NJ,
USA). Thereafter, 30 g of pre-conditioned grain were
added to the glass bottles along with two Teflon balls
(1/2” diameter) and autoclaved (20 min, 121°C). Once
cooled, each bottle was independently inoculated with
4 ml spore suspension (5 9 105 spores ml-1) of an
atoxigenic isolate. To allow sterile aeration, each bottle
was covered with sterile Tyvek membrane (7 cm2)
secured with a sterile polypropylene pour ring (GL 45;
DWK Life Sciences, Rockwood, TN, USA). The mem-
brane allows gas exchange, but its pores are not large
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enough to provide access or escape of microorgan-
isms. All bottles were incubated for 7 days (35°C,
dark). There were six bottles per isolate (24 bottles in
total) which yield enough spores to manufacture six
tons of biocontrol product.
Harvesting and drying of atoxigenic A. flavus isolates
After incubation, all bottles were transferred to a biosaf-
ety level 2 cabinet. Tyvek membranes were aseptically
removed and 125 ml sterile 0.03% TWEEN20 was
added to each bottle. Then, bottles were covered with
sterile plastic caps, tightly closed, and placed on a Roto-
Shake Genie reciprocal shaker (Scientific Industries,
Bohemia, NY, USA) to dislodge spores (200 rpm,
20 min). The Teflon balls aided dislodging spores from
sorghum grains (Agbetiameh et al., 2019). Sterile funnels
holding sterile sieves (1.7 mm2; Newark Wire Cloth Co.,
Clifton, NJ, USA) were used to separate grains from the
suspension (Fig. 1A). Dislodged spores in suspension
were transferred to sterile 250 ml glass bottles and
tightly covered with sterile caps (Fig. 1B). These spore
suspensions were either appropriately diluted and ter-
med as freshly produced spores or further processed to
produce dry spores.
Spores were separated from liquid using a vacuum
pump (1 stage Vacuum Pump, VE 125; Nanjing T-Bota
Scietech Instrument and Equipment Co. Ltd., Nanjing,
China) attached to 500 ml filtration flasks. A single piece
of sterile Tyvek membrane was cut to fit sterile vacuum
funnels (Fig. 1C). Suspensions were slowly poured in
the centre of the membrane. After filtration, spores
remained on the membrane as a crust and were almost
completely dry. Using sterile spatulas, the spore crusts
were transferred to sterile, labelled 40 ml glass vials
(Fig. 1D). Vials were covered with sterile Tyvek mem-
brane (5 cm2) secured with a rubber band disinfected
with 70% ethanol, wrapped in foil paper, and dried in a
forced-air oven (37°C, 48 h). After drying, vials contain-
ing the dry spores were stored at room temperature
(~25°C) until used in the evaluations.
Assessment of viability of dry spores and freshly
produced spores
The viability of dry spores was evaluated after 2, 5, 10,
15, and 30 days of storage. In each evaluation, freshly
harvested spores were used as control to determine if
the drying process and storage period influenced spore
viability (spore germination) and/or allowed microbial
contamination of dry spores. From each vial containing
dry spores, 0.3 g were aseptically transferred to sterile
40 ml glass vials containing 29.7 ml sterile distilled
water. The suspension (3 9 109 spores ml-1) was
vortexed and 600 µl aliquots were uniformly spread in
triplicates on both water agar (WA; 2% Bacto-agar) and
violet red bile agar (VRBA; Difco Laboratories Inc.,
41.5 g l-1, pH 7.4). For fresh spores (harvested ~ 20 min
prior to plating), suspensions containing the same con-
centration as above were plated. All plates were incu-
bated at 31°C for 2 days.
Biocontrol product preparation using dry spores and
freshly harvested spores
The same spore suspensions used to assess spore via-
bility of dry spores and freshly harvested spores were
used to manually prepare biocontrol products using a
laboratory-scale process. Briefly, for both dry spores and
freshly harvested spores, the suspensions of each atoxi-
genic isolate were adjusted to 4 9 107 spores ml-1 and
used to prepare experimental products containing single
isolates. For each isolate, 10 ml adjusted spore suspen-
sion was mixed with 10.5 ml sterile distilled water,
1.5 ml polymer (SentryTM, Precision Laboratories, Wau-
kegan, IL, USA), and 2 ml blue dye (PrismTM, Milliken &
Company, Spartanburg, SC, USA) to coat 1 kg of sterile
roasted sorghum grain. Coating was performed by man-
ually shaking the required quantity of sterile sorghum
grain and spore–polymer–dye suspension in a container
until the grains were uniformly blue in colour. All manu-
ally produced products were subjected to standard qual-
ity tests as described previously (Agbetiameh et al.,
2019; Senghor et al., 2020). These tests determined (i)
proportions of germinated grains, (ii) grains with A. flavus
growth, (iii) grains with other microbial (fungi or bacteria)
growth, (iv) number of spores produced per g of product,
and (v) identity of the A. flavus fungi recovered from the
grains.
Production of dry spores sent to Kahone, Senegal
Dry spores enough to manufacture 200 tons of Aflasafe
SN01 were produced in Ibadan as described above. In
total, 200 bottles containing sterile pre-conditioned sor-
ghum grain were inoculated per atoxigenic isolate. Two
batches were produced, 100 bottles per isolate per
batch, on 30 April 2019 and 3 June 2019. In all, 4 kg of
dry spores were produced and sent to Dakar via air
freight under appropriate export permit from the Nigeria
Agricultural Quarantine Service and import permit from
La Direction de Protection Vegetaux (DPV) of Senegal.
The dry spores were placed in sterile 40 ml glass vials
tightly closed and sent within sealed cardboard boxes.
After transport via road at ambient temperature from
Dakar to BAMTAARE plant in Kahone (~3 h drive), the
dry spores were kept at 4°C until used to manufacture
the product during July and August 2019.
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Manufacturing and quality control of Aflasafe SN01
produced in Kahone using dry spores
In Kahone, 5 g dry spores of each atoxigenic isolate
(20 g total) were combined with 10 l sterile distilled
water (resulting in 4 9 107 spores ml-1) to prepare 1
ton of Aflasafe SN01 product (Fig. 2). The suspension
was placed in polypropylene carboys (VWR, Radnor,
PA, USA), combined with 10.5 l sterile water, 1.5 l poly-
mer and 2 l blue dye, agitated for proper mixing, and
used to coat roasted, sterile sorghum grain with a seed
treater (Fig. 2). Quality tests for all batches (n = 360;
two per ton) of product industrially manufactured with
dry spores were conducted in Kahone as previously
described (Agbetiameh et al., 2019; Senghor et al.,
2020).
Paired field evaluation of biocontrol products
manufactured with dry spores and conventionally
Commercial usage of Aflasafe SN01 in Senegal and The
Gambia by smallholder farmers started in 2016. Before
constructing its manufacturing facility, BAMTAARE pro-
cured the conventionally manufactured product from the
IITA-Ibadan plant (Bandyopadhyay et al., 2016; Senghor
et al., 2020). BAMTAREE procured 20, 50, and 200 tons
of product in 2016, 2017, and 2018, respectively, for use
in Senegal and The Gambia. Part of the product manu-
factured in 2018 (conventional product) was used in
2019 in The Gambia. The performance of Aflasafe SN01
manufactured in 2018 and used in 2019 was compared
with that of product manufactured with dry spores and
also used in 2019 (Table 2).
Farmers belonging to The National Food Security,
Processing and Marketing Corporation (NFSPMC) of
The Gambia participated in the commercial comparison
trials. NFSPMC farmers have used the biocontrol pro-
duct since the testing phase (2014–2015) and due to
periodic training and usage are familiar with the applica-
tion method and practices to maximize the product’s
effectiveness (Senghor et al., 2020). The trials were con-
ducted in the Central River and North Bank regions, with
20 treated fields per region (i.e. 10 with conventional
product from 2018 and 10 with dry spore product from
2019).
Farmers grew their groundnut crops following recom-
mendations given by NFSPMC. Farmers planted either
28–206 [a late-maturity variety; 125 days growing
cycle; flowering time ~ 45 days after planting (dap)] or
73–33 (an intermediate-maturing variety; 115 days
growing cycle; flowering time ~ 40 dap) two of the most
common groundnut varieties in The Gambia (ICRISAT,
1990). In general, groundnut crops were planted after
the first rains during the first week of July. Farmers
weeded their fields by hand and animal-drawn hoe,
top-dressed with a complex fertilizer, and earthed-up
(i.e. piling up soil around the base of the plants) before
application of the biocontrol product to avoid burying it.
The products were broadcasted by hand at a rate of
10 kg ha-1 at 30-to-35 dap. For each treated field, a
neighbouring field–managed by the same farmer and
planted with the same variety–at least 200 m apart
was selected as the corresponding untreated field.
Field sizes ranged from 0.5 to 2 ha. Production of
groundnut in all fields was dependent on rainfalls,
which were erratic.
Field evaluations in Senegal and The Gambia of
biocontrol products manufactured with the conventional
method (2018) and with dry spores (2019)
Although not paired comparisons, and conducted in dif-
ferent years, biocontrol effectiveness was also moni-
tored in Senegal and The Gambia. In The Gambia,
conventional product was used by NFSPMC farmers in
2018 while dry spore product was used in 2019 by both
NFSPMC farmers and farmers participating in a Food
and Agriculture Organization (FAO) scheme. All of
these were groundnut trials conducted in multiple fields
(either 10 or 15 treated fields) of multiple regions
(Table 3). Each treated field had an accompanying
untreated field as above. The results of the 2018 trials
by NFSPMC farmers have been reported (Senghor
et al., 2021).
In Senegal in 2018, conventional product was used in
both maize and groundnut fields of farmers working with
BAMTAARE in five regions (Table S1). There were 15
treated fields per region and each field had an accompa-
nying untreated field as above. In 2019, farmers working
either with BAMTAARE or the Association Senegalaise
pour la Promotion du Developpement par la Base
(ASPRODEB) treated maize and/or groundnut fields with
dry spore product (Table S1). There were 10–30 treated
fields in each of the four regions and each treated field
had an accompanying untreated field.
Groundnut varieties, planting time and agronomic
practices were similar as those described above for The
Gambia. For maize, farmers planted diverse improved or
landrace varieties that flowered around 60 to 70 dap.
Maize was also planted during the first week of July after
the first rains. Farmers weeded their maize by hand and
animal-drawn hoe, top-dressed with urea, and earthed-
up before broadcasting the biocontrol product by hand 2-
to-3 weeks before flowering. For each treated maize
field, a neighbouring untreated maize field was main-
tained in a similar manner as groundnut. Field sizes ran-
ged from 0.5 to 5 ha. Crop production in all fields was
dependent on rainfalls, which were erratic.
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Crop sampling and aflatoxin quantification
Regardless of treatment, year, and country, crops were
harvested at physiological maturity. In all trials, extension
agents collected representative grain samples (~2 kg)
from each field. Aflatoxin quantification in The Gambia
was conducted at NFSPMC and FAO premises by
NFSPMC technicians. In Senegal, aflatoxin quantification
was done at BAMTAARE and ASPRODEB premises by
BAMTAARE technicians.
In both countries, some farmers participated in the
aflatoxin testing process whereas others were observers.
GIPSA-approved Neogen Reveal Q + for Aflatoxin kits
(Neogen Corp., Lansing, MI, USA) were used. Briefly,
grains were milled using a laboratory blender (Waring
Commercial, Springfield, MO, USA) for 30 sec in a 1-l
stainless steel blending jar (MC-2). The jar was thor-
oughly washed with 80% ethanol to prevent aflatoxin
cross contamination between samples. For each sample,
a 20-g sub-sample was transferred into a 250 ml glass
bottle and 100 ml 65% ethanol was added. The mixture
was shaken by hand (3 min), allowed to settle (3 min)
and filtered through Whatman No. 1 filter paper (What-
man Intl. Ltd., Maidstone, UK) into a Tri-Pour beaker.
Thereafter, 500 µl sample diluent was transferred to a
sample cup and 100 µl sample filtrate was added. A
100 µl aliquot of diluted sample was transferred into a
new cup and mixed thoroughly by aspiration. A lateral
flow strip was placed in the sample cup for 6 min and
then the strip was read on a Neogene AccuScan Gold
Reader. The limit of detection was 1 part per billion
(ppb) total aflatoxin.
Data analyses
Data were summarized and analysed using SAS v9.4
(SAS Institute Inc., Cary, NC, USA). Data for all depen-
dent variables (CFU/g of dry spores, CFU/grain of formu-
lated product and aflatoxin levels in treated and untreated
crops) were log-transformed, using the equation [y = log
(response variable + 1)] to homogenize the variance prior
to analysis. CFU means between dry spores and freshly
harvested spores, and in aflatoxin content means
between treated and untreated crops in both The Gambia
and Senegal were compared with Student’s t-test
(a = 0.05) using the TTEST procedure of SAS.
CFU/grain data were subjected to a factorial ANOVA
to determine the differences among Dry and Fresh
spores, isolates, storage period, and their interactions.
The treatment means were compared according to
Tukey HSD test (a = 0.05).
For the field comparison of the two formulations in
The Gambia in 2019, Conventional and Dry Spore, the
Kruskal–Wallis one-way nonparametric test was
performed and total aflatoxin means were compared at
a = 0.05. For the field comparison in The Gambia con-
ducted in different years, data were subjected to a facto-
rial ANOVA to determine the differences among regions,
farmers’ organizations, year, formulation, treatment, and
their interactions. The treatment means were compared
according to Tukey HSD test (a = 0.05).
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